Clinical Trials Market In US 2026-2030
Description
Clinical Trials Market In US 2026-2030
The clinical trials market in us is forecasted to grow by USD 7021.4 mn during 2025-2030, accelerating at a CAGR of 5.4% during the forecast period. The report on the clinical trials market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by robust growth in research and development expenditures, proliferation of outsourcing to contract research organizations, technological advancements and adoption of digital and decentralized trial models.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's clinical trials market in us is segmented as below:
By Type
The report on the clinical trials market in us covers the following areas:
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
The clinical trials market in us is forecasted to grow by USD 7021.4 mn during 2025-2030, accelerating at a CAGR of 5.4% during the forecast period. The report on the clinical trials market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by robust growth in research and development expenditures, proliferation of outsourcing to contract research organizations, technological advancements and adoption of digital and decentralized trial models.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's clinical trials market in us is segmented as below:
By Type
- Phase III
- Phase I
- Phase II
- Phase IV
- Interventional studies
- Observational studies
- Expanded access studies
- Oncology
- CNS
- Autoimmune or inflammation
- Others
- North America
- US
The report on the clinical trials market in us covers the following areas:
- Clinical trials market in us sizing
- Clinical trials market in us forecast
- Clinical trials market in us industry analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
195 Pages
- 1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Country Market Characteristics
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Service Type
- Executive Summary - Chart on Market Segmentation by Indication
- Executive Summary - Chart on Company Market Positioning
- 2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 3 Market Landscape
- 3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Chart on Market characteristics analysis
- 3.3 Value chain analysis
- Chart on Value chain analysis
- 4 Market Sizing
- 4.1 Market definition
- Data Table on Offerings of companies included in the market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US: Year-over-year growth 2025-2030 (%)
- Data Table on US: Year-over-year growth 2025-2030 (%)
- 5 Historic Market Size
- 5.1 Clinical Trials Market in US 2020 - 2024
- Historic Market Size - Data Table on Clinical Trials Market in US 2020 - 2024 ($ million)
- 5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.3 Service Type segment analysis 2020 - 2024
- Historic Market Size - Service Type Segment 2020 - 2024 ($ million)
- 5.4 Indication segment analysis 2020 - 2024
- Historic Market Size - Indication Segment 2020 - 2024 ($ million)
- 6 Qualitative Analysis
- 6.1 Impact of AI on clinical trials market in US
- 6.2 Impact of geopolitical conflicts on clinical trials market in US
- 7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
- Chart on Market condition - Five forces 2025 and 2030
- 8 Market Segmentation by Type
- 8.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
- 8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 8.3 Phase III - Market size and forecast 2025-2030
- Chart on Phase III - Market size and forecast 2025-2030 ($ million)
- Data Table on Phase III - Market size and forecast 2025-2030 ($ million)
- Chart on Phase III - Year-over-year growth 2025-2030 (%)
- Data Table on Phase III - Year-over-year growth 2025-2030 (%)
- 8.4 Phase I - Market size and forecast 2025-2030
- Chart on Phase I - Market size and forecast 2025-2030 ($ million)
- Data Table on Phase I - Market size and forecast 2025-2030 ($ million)
- Chart on Phase I - Year-over-year growth 2025-2030 (%)
- Data Table on Phase I - Year-over-year growth 2025-2030 (%)
- 8.5 Phase II - Market size and forecast 2025-2030
- Chart on Phase II - Market size and forecast 2025-2030 ($ million)
- Data Table on Phase II - Market size and forecast 2025-2030 ($ million)
- Chart on Phase II - Year-over-year growth 2025-2030 (%)
- Data Table on Phase II - Year-over-year growth 2025-2030 (%)
- 8.6 Phase IV - Market size and forecast 2025-2030
- Chart on Phase IV - Market size and forecast 2025-2030 ($ million)
- Data Table on Phase IV - Market size and forecast 2025-2030 ($ million)
- Chart on Phase IV - Year-over-year growth 2025-2030 (%)
- Data Table on Phase IV - Year-over-year growth 2025-2030 (%)
- 8.7 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
- 9 Market Segmentation by Service Type
- 9.1 Market segments
- Chart on Service Type - Market share 2025-2030 (%)
- Data Table on Service Type - Market share 2025-2030 (%)
- 9.2 Comparison by Service Type
- Chart on Comparison by Service Type
- Data Table on Comparison by Service Type
- 9.3 Interventional studies - Market size and forecast 2025-2030
- Chart on Interventional studies - Market size and forecast 2025-2030 ($ million)
- Data Table on Interventional studies - Market size and forecast 2025-2030 ($ million)
- Chart on Interventional studies - Year-over-year growth 2025-2030 (%)
- Data Table on Interventional studies - Year-over-year growth 2025-2030 (%)
- 9.4 Observational studies - Market size and forecast 2025-2030
- Chart on Observational studies - Market size and forecast 2025-2030 ($ million)
- Data Table on Observational studies - Market size and forecast 2025-2030 ($ million)
- Chart on Observational studies - Year-over-year growth 2025-2030 (%)
- Data Table on Observational studies - Year-over-year growth 2025-2030 (%)
- 9.5 Expanded access studies - Market size and forecast 2025-2030
- Chart on Expanded access studies - Market size and forecast 2025-2030 ($ million)
- Data Table on Expanded access studies - Market size and forecast 2025-2030 ($ million)
- Chart on Expanded access studies - Year-over-year growth 2025-2030 (%)
- Data Table on Expanded access studies - Year-over-year growth 2025-2030 (%)
- 9.6 Market opportunity by Service Type
- Market opportunity by Service Type ($ million)
- Data Table on Market opportunity by Service Type ($ million)
- 10 Market Segmentation by Indication
- 10.1 Market segments
- Chart on Indication - Market share 2025-2030 (%)
- Data Table on Indication - Market share 2025-2030 (%)
- 10.2 Comparison by Indication
- Chart on Comparison by Indication
- Data Table on Comparison by Indication
- 10.3 Oncology - Market size and forecast 2025-2030
- Chart on Oncology - Market size and forecast 2025-2030 ($ million)
- Data Table on Oncology - Market size and forecast 2025-2030 ($ million)
- Chart on Oncology - Year-over-year growth 2025-2030 (%)
- Data Table on Oncology - Year-over-year growth 2025-2030 (%)
- 10.4 CNS - Market size and forecast 2025-2030
- Chart on CNS - Market size and forecast 2025-2030 ($ million)
- Data Table on CNS - Market size and forecast 2025-2030 ($ million)
- Chart on CNS - Year-over-year growth 2025-2030 (%)
- Data Table on CNS - Year-over-year growth 2025-2030 (%)
- 10.5 Autoimmune or inflammation - Market size and forecast 2025-2030
- Chart on Autoimmune or inflammation - Market size and forecast 2025-2030 ($ million)
- Data Table on Autoimmune or inflammation - Market size and forecast 2025-2030 ($ million)
- Chart on Autoimmune or inflammation - Year-over-year growth 2025-2030 (%)
- Data Table on Autoimmune or inflammation - Year-over-year growth 2025-2030 (%)
- 10.6 Others - Market size and forecast 2025-2030
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- 10.7 Market opportunity by Indication
- Market opportunity by Indication ($ million)
- Data Table on Market opportunity by Indication ($ million)
- 11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 12 Drivers, Challenges, and Opportunity
- 12.1 Market drivers
- Robust growth in research and development expenditures
- Proliferation of outsourcing to contract research organizations
- Technological advancements and adoption of digital and decentralized trial models
- 12.2 Market challenges
- Systemic hurdles in patient recruitment and retention
- Escalating operational costs and logistical complexity
- Navigating dynamic and fragmented regulatory and data privacy landscape
- 12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 12.4 Market opportunities
- Ascendancy of decentralized and hybrid trial models
- Convergence of artificial intelligence and real world evidence
- Proliferation of complex and adaptive trial designs in era of precision medicine
- 13 Competitive Landscape
- 13.1 Overview
- 13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 13.3 Landscape disruption
- Overview on factors of disruption
- 13.4 Industry risks
- Impact of key risks on business
- 14 Competitive Analysis
- 14.1 Companies profiled
- Companies covered
- 14.2 Company ranking index
- Company ranking index
- 14.3 Market positioning of companies
- Matrix on companies position and classification
- 14.4 Caidya
- Caidya - Overview
- Caidya - Product / Service
- Caidya - Key offerings
- SWOT
- 14.5 Charles River Laboratories International Inc.
- Charles River Laboratories International Inc. - Overview
- Charles River Laboratories International Inc. - Business segments
- Charles River Laboratories International Inc. - Key offerings
- Charles River Laboratories International Inc. - Segment focus
- SWOT
- 14.6 Clario
- Clario - Overview
- Clario - Product / Service
- Clario - Key offerings
- SWOT
- 14.7 Fortrea Holdings Inc
- Fortrea Holdings Inc - Overview
- Fortrea Holdings Inc - Product / Service
- Fortrea Holdings Inc - Key offerings
- SWOT
- 14.8 ICON plc
- ICON plc - Overview
- ICON plc - Product / Service
- ICON plc - Key offerings
- SWOT
- 14.9 IQVIA Holdings Inc.
- IQVIA Holdings Inc. - Overview
- IQVIA Holdings Inc. - Business segments
- IQVIA Holdings Inc. - Key offerings
- IQVIA Holdings Inc. - Segment focus
- SWOT
- 14.10 Laboratory Holdings Inc.
- Laboratory Holdings Inc. - Overview
- Laboratory Holdings Inc. - Business segments
- Laboratory Holdings Inc. - Key news
- Laboratory Holdings Inc. - Key offerings
- Laboratory Holdings Inc. - Segment focus
- SWOT
- 14.11 Medelis Inc.
- Medelis Inc. - Overview
- Medelis Inc. - Product / Service
- Medelis Inc. - Key offerings
- SWOT
- 14.12 Medpace Holdings Inc.
- Medpace Holdings Inc. - Overview
- Medpace Holdings Inc. - Product / Service
- Medpace Holdings Inc. - Key offerings
- SWOT
- 14.13 Parexel International Corp.
- Parexel International Corp. - Overview
- Parexel International Corp. - Product / Service
- Parexel International Corp. - Key offerings
- SWOT
- 14.14 Rho Inc.
- Rho Inc. - Overview
- Rho Inc. - Product / Service
- Rho Inc. - Key offerings
- SWOT
- 14.15 Suvoda LLC
- Suvoda LLC - Overview
- Suvoda LLC - Product / Service
- Suvoda LLC - Key offerings
- SWOT
- 14.16 Syneos Health Inc.
- Syneos Health Inc. - Overview
- Syneos Health Inc. - Product / Service
- Syneos Health Inc. - Key offerings
- SWOT
- 14.17 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
- 14.18 Veristat LLC
- Veristat LLC - Overview
- Veristat LLC - Product / Service
- Veristat LLC - Key offerings
- SWOT
- 15 Appendix
- 15.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 15.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 15.4 Research methodology
- Research methodology
- 15.5 Data procurement
- Information sources
- 15.6 Data validation
- Data validation
- 15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 15.8 Data synthesis
- Data synthesis
- 15.9 360 degree market analysis
- 360 degree market analysis
- 15.10 List of abbreviations
- List of abbreviations
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
